Prostatic neoplasms, castration-resistant Clinical Trials
Conditions / Prostatic neoplasms, castration-resistant
Delta Trials indexes 1 clinical trial for Prostatic neoplasms, castration-resistant in its publicly accessible dataset. Of these, 1 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 85 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
85
Study Locations
Browse by location (85 total)
- Hershey, United States 1 trialAll trials in Hershey, United States
- Santa Monica, United States 1 trialAll trials in Santa Monica, United States
- Preston, United Kingdom 1 trialAll trials in Preston, United Kingdom
- Nanjing, China 1 trialAll trials in Nanjing, China
- Glasgow, United Kingdom 1 trialAll trials in Glasgow, United Kingdom
- Myrtle Beach, United States 1 trialAll trials in Myrtle Beach, United States
- Kuching, Malaysia 1 trialAll trials in Kuching, Malaysia
- Québec, Canada 1 trialAll trials in Québec, Canada
- Saint Paul, United States 1 trialAll trials in Saint Paul, United States
- Bauru, Brazil 1 trialAll trials in Bauru, Brazil
- Sagamihara, Japan 1 trialAll trials in Sagamihara, Japan
- Seville, Spain 1 trialAll trials in Seville, Spain
- Tainan, Taiwan 1 trialAll trials in Tainan, Taiwan
- Wuhan, China 1 trialAll trials in Wuhan, China
- All trials in Newcastle upon Tyne, United Kingdom
- Yokohama, Japan 1 trialAll trials in Yokohama, Japan
- Kanazawa, Japan 1 trialAll trials in Kanazawa, Japan
- Lille, France 1 trialAll trials in Lille, France
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Liège, Belgium 1 trialAll trials in Liège, Belgium